Key Summary
- Various researches have proven that patients who use weight loss drugg like Wegovy and Ozempic regain weight within 18 months if stopping the medicines.
- Along with the weight, type two diabetes and heart health risks also return.
- Healthy diet and exercise is a good way to keep the weight, diabetes and heart health in control over medicines.
Many studies have earlier highlighted the high risk of weight regain after stopping the usage of GLP-1 drugs such Ozempic, Wegovy, etc. among the users.
A study published in the British Medical Journal (BMJ) assessing over 37 earlier studies pointed out that along with the weight gain, the risk of diabetes and cardiovascular health problems also returns.
GLP-1 users gain the lost weight within 18 months (four times more) compared with people who go on diet and do exercise.
These drugs reduce craving and provide a sense of fullness for the users, while rapid weight gain comes as the side-effect.
The active ingredient semaglutide helps in the management of type 2 diabetes and cardiovascular health issues are a major advantage of these drugs.
Those who adopt healthier eating patterns do not experience this weight relapse.
Another study states that weight management must be a comprehensive approach rather than the short-term solutions, obesity is a chronic and relapsing health condition.
So, representatives of School of Clinical Medicine and Trinity College opine that pausing the use of weight loss drugs must be followed with healthy diet and proper exercise to continue to avoid the medications in life.
It will also prevent, obesity, diabetes and heart health issues without the support of medicines.
